Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV-1 | 11 | 2021 | 6711 | 1.100 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 3 | 2015 | 347 | 1.040 |
Why?
|
Viral Envelope Proteins | 4 | 2013 | 607 | 0.820 |
Why?
|
HIV Infections | 12 | 2021 | 14979 | 0.580 |
Why?
|
Integrins | 2 | 2013 | 884 | 0.470 |
Why?
|
Genome, Viral | 2 | 2018 | 697 | 0.460 |
Why?
|
Substance Abuse, Intravenous | 1 | 2014 | 449 | 0.430 |
Why?
|
Anti-Retroviral Agents | 2 | 2021 | 1513 | 0.420 |
Why?
|
Withholding Treatment | 3 | 2021 | 600 | 0.420 |
Why?
|
Dengue Virus | 2 | 2008 | 182 | 0.390 |
Why?
|
Pichia | 1 | 2008 | 51 | 0.370 |
Why?
|
Genetic Variation | 2 | 2015 | 6772 | 0.360 |
Why?
|
Receptors, CCR5 | 1 | 2009 | 449 | 0.340 |
Why?
|
Polymerase Chain Reaction | 2 | 2015 | 6464 | 0.330 |
Why?
|
Antigens, Viral | 2 | 2008 | 1146 | 0.320 |
Why?
|
Fetal Distress | 1 | 2022 | 43 | 0.240 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2013 | 4355 | 0.230 |
Why?
|
Proviruses | 2 | 2021 | 263 | 0.220 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2013 | 4115 | 0.220 |
Why?
|
Antibodies, Viral | 2 | 2008 | 2536 | 0.210 |
Why?
|
Fetal Death | 1 | 2022 | 458 | 0.200 |
Why?
|
Receptors, HIV | 2 | 2016 | 143 | 0.190 |
Why?
|
HIV Antibodies | 3 | 2016 | 1201 | 0.180 |
Why?
|
Neutralization Tests | 3 | 2016 | 702 | 0.180 |
Why?
|
HIV Long-Term Survivors | 1 | 2018 | 134 | 0.170 |
Why?
|
Virus Replication | 3 | 2016 | 2589 | 0.170 |
Why?
|
Genotype | 4 | 2021 | 13073 | 0.150 |
Why?
|
Anti-HIV Agents | 3 | 2021 | 3955 | 0.140 |
Why?
|
Dengue | 2 | 2008 | 230 | 0.140 |
Why?
|
Cytological Techniques | 1 | 2016 | 223 | 0.140 |
Why?
|
Antibodies, Neutralizing | 2 | 2015 | 1572 | 0.140 |
Why?
|
Drug Resistance, Viral | 2 | 2021 | 805 | 0.130 |
Why?
|
CD4 Lymphocyte Count | 2 | 2017 | 2578 | 0.130 |
Why?
|
Placenta | 1 | 2022 | 1353 | 0.130 |
Why?
|
Remission Induction | 1 | 2019 | 2387 | 0.130 |
Why?
|
Viral Load | 3 | 2018 | 3216 | 0.130 |
Why?
|
Immunity, Humoral | 1 | 2016 | 554 | 0.120 |
Why?
|
Heterosexuality | 1 | 2013 | 270 | 0.110 |
Why?
|
Cell Line | 3 | 2015 | 17137 | 0.110 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 731 | 0.110 |
Why?
|
Antigens | 1 | 2016 | 1496 | 0.110 |
Why?
|
RNA, Viral | 2 | 2021 | 2823 | 0.110 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 737 | 0.110 |
Why?
|
Serotyping | 2 | 2008 | 375 | 0.110 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 1910 | 0.110 |
Why?
|
Virulence | 1 | 2014 | 1309 | 0.100 |
Why?
|
Glycosylation | 1 | 2013 | 1162 | 0.100 |
Why?
|
Gastric Mucosa | 1 | 2013 | 714 | 0.100 |
Why?
|
Immunity, Mucosal | 1 | 2013 | 496 | 0.100 |
Why?
|
Dengue Vaccines | 1 | 2008 | 15 | 0.090 |
Why?
|
Inhibitory Concentration 50 | 1 | 2009 | 459 | 0.090 |
Why?
|
Family Characteristics | 1 | 2013 | 957 | 0.090 |
Why?
|
Culicidae | 1 | 2008 | 101 | 0.090 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2008 | 414 | 0.090 |
Why?
|
Haplorhini | 1 | 2008 | 602 | 0.090 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1516 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 8070 | 0.070 |
Why?
|
Mutation, Missense | 1 | 2014 | 2570 | 0.070 |
Why?
|
Cricetinae | 1 | 2008 | 2624 | 0.070 |
Why?
|
Binding Sites | 1 | 2013 | 6499 | 0.070 |
Why?
|
Macrophages | 3 | 2021 | 5748 | 0.060 |
Why?
|
Monocytes | 2 | 2012 | 2643 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 5044 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2013 | 20620 | 0.060 |
Why?
|
Genetic Engineering | 1 | 2008 | 942 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2014 | 2625 | 0.060 |
Why?
|
Spleen | 1 | 2008 | 2570 | 0.060 |
Why?
|
Humans | 17 | 2022 | 686663 | 0.060 |
Why?
|
Chorioamnionitis | 1 | 2022 | 150 | 0.060 |
Why?
|
Mice, Inbred BALB C | 2 | 2008 | 6786 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 4184 | 0.060 |
Why?
|
Viral Vaccines | 1 | 2006 | 567 | 0.050 |
Why?
|
Kinetics | 1 | 2009 | 6979 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 14656 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 19328 | 0.050 |
Why?
|
Glycomics | 1 | 2021 | 125 | 0.050 |
Why?
|
HIV Envelope Protein gp120 | 2 | 2016 | 902 | 0.050 |
Why?
|
Virus Activation | 1 | 2021 | 325 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 3983 | 0.050 |
Why?
|
Cohort Studies | 3 | 2021 | 38732 | 0.050 |
Why?
|
Defective Viruses | 1 | 2018 | 117 | 0.050 |
Why?
|
Coculture Techniques | 2 | 2013 | 1393 | 0.050 |
Why?
|
Disease Reservoirs | 1 | 2018 | 144 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2013 | 13444 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16091 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1461 | 0.040 |
Why?
|
Viral Tropism | 1 | 2016 | 97 | 0.040 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2022 | 1276 | 0.030 |
Why?
|
DNA, Viral | 1 | 2021 | 2341 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 341 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2863 | 0.030 |
Why?
|
Protein Binding | 2 | 2016 | 9947 | 0.030 |
Why?
|
Metabolomics | 1 | 2021 | 1299 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 558 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 10102 | 0.030 |
Why?
|
Cell-Free System | 1 | 2012 | 387 | 0.030 |
Why?
|
Dendritic Cells | 2 | 2013 | 2779 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2008 | 10329 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1626 | 0.020 |
Why?
|
Female | 6 | 2022 | 375459 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2013 | 907 | 0.020 |
Why?
|
Mice | 3 | 2016 | 80803 | 0.020 |
Why?
|
Male | 5 | 2021 | 352465 | 0.020 |
Why?
|
Mutation | 2 | 2021 | 28848 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12525 | 0.020 |
Why?
|
Adult | 4 | 2022 | 211400 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8198 | 0.020 |
Why?
|
Vaccines, Synthetic | 1 | 2006 | 540 | 0.020 |
Why?
|
Animals | 3 | 2016 | 170849 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 11019 | 0.020 |
Why?
|
Inflammation | 1 | 2021 | 9617 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 25703 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 216468 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 7060 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 9863 | 0.010 |
Why?
|
Escherichia coli | 1 | 2006 | 4411 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 42271 | 0.010 |
Why?
|
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(36)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_